LMDX

Stats

Summary

healthcare organizations continue to wrestle with avoidable costs, preventable errors, and operational inefficiency, all while aspiring to improve their consumer experience, outcomes, and bottom line. meanwhile our economies continue to be challenged by rising healthcare costs attributable to fragmented care and long term conditions, especially diabetes, heart failure, copd, and their co-morbidities. common approaches to address these challenges – rip-and-replace information systems, deploy siloed programs that hope to “manage” high-risk patients, use minimally interconnected systems to coordinate care – have proven exorbitantly expensive, unduly cumbersome, financially unsustainable, and eventually inadequate to achieve desired benefits. lumiradx offers proven solutions to directly address these challenges, and partners with its clients to help achieve better health care, social care, and financial outcomes, an improved consumer experience, and the agility to continue this transformat

Market Cap: 7 Million

Primary Exchange: NASDAQ

Website:

Shares Outstanding: 164 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: -0.7059473779290104

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 680 trading days

From: 2021-11-17 To: 2024-01-04

Lowest Point: